Harnessing heterogeneity in type 2 diabetes mellitus
Nature Reviews Endocrinology, Published online: 12 December 2019; doi:10.1038/s41574-019-0308-1Personalized, or precision, medicine in type 2 diabetes mellitus is becoming a reality with new insights into the contributions of subgroup analyses. The roadmap to future implementation must take into account individual and subgroup variability in genetic architecture, environment, clinical measures, lifestyle, cost-effectiveness and treatment burden.
Source: Nature Reviews Endocrinology - Category: Endocrinology Authors: Louis H. Philipson Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Environmental Health | Genetics